ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,475 | -31.6% | 3,146,833 | -3.9% | 0.02% | -23.1% |
| Q2 2023 | $21,158 | -13.5% | 3,275,301 | +1.0% | 0.03% | -18.8% |
| Q1 2023 | $24,453 | -16.9% | 3,243,199 | +11.6% | 0.03% | -22.0% |
| Q4 2022 | $29,439 | -99.9% | 2,906,212 | -11.5% | 0.04% | -12.8% |
| Q3 2022 | $32,488,000 | -8.8% | 3,285,022 | -1.8% | 0.05% | -2.1% |
| Q2 2022 | $35,640,000 | +14.6% | 3,346,497 | +4.9% | 0.05% | +33.3% |
| Q1 2022 | $31,100,000 | +648.1% | 3,189,837 | +997.1% | 0.04% | +800.0% |
| Q4 2021 | $4,157,000 | +47.2% | 290,746 | +106.2% | 0.00% | +33.3% |
| Q3 2021 | $2,825,000 | – | 141,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |